Ryaltris TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: olopatadine + mometasone
Brand name
(ARTG)
: RYALTRIS olopatadine 600 microgram/actuation and mometasone furoate 25 microgram/actuation nasal spray bottleDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
RYALTRIS is indicated for the treatment of symptoms associated with allergic rhinitis and rhinoconjunctivitis in patients 6 years of age and older.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Spray, nasal
- Nasal
- Aqueous white homogenous suspension filled into a white opaque high density polyethylene bottle, fitted with spray pump, nasal actuator and dust cap.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Do not Freeze
- Do not Refrigerate
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 120 doses per bottle pack
- 240 doses per bottle pack
- 56 doses per bottle pack
- 56 doses per bottle (Starter pack) pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient olopatadine + mometasone
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
